Background and activities
Scientific, academic and artistic work
A selection of recent journal publications, artistic productions, books, including book and report excerpts. See all publications in the database
- (2018) Signals from the south; humpback whales carry messages of Antarctic sea‐ice ecosystem variability. Global Change Biology. vol. 24 (4).
- (2018) Vaccination of koalas (Phascolarctos cinereus) against Chlamydia pecorum using synthetic peptides derived from the major outer membrane protein. PLoS ONE.
- (2018) Prevalence of Chlamydia pecorum in Juvenile Koalas ( Phascolarctos cinereus ) and Evidence for Protection from Infection via Maternal Immunization. Journal of Wildlife Diseases.
- (2018) Deregulation of microRNA-155 and its transcription factor NF-kB by polychlorinated biphenyls during viral infection. APMIS : Acta pathologica, microbiologica et immunologica Scandinavica. Supplementum. vol. 126 (3).
- (2017) Expanding the 3R principles: More rigour and transparency in research using animals. EMBO Reports. vol. 18 (9).
- (2017) Systemic Antibody Response to Chlamydia Trachomatis Infection in Patients Either Infected or Reinfected with Different Chlamydia Serovars. Indian Journal of Medical Microbiology. vol. 35 (3).
- (2017) Epidemiology of chlamydial infection and disease in a free-ranging koala (Phascolarctos cinereus) population. PLoS ONE. vol. 12:e0190114 (12).
- (2017) Infection with koala retrovirus subgroup B (KoRV-B), but not KoRV-A, is associated with chlamydial disease in free-ranging koalas (Phascolarctos cinereus). Scientific Reports. vol. 7 (134).
- (2016) Antibody and Cytokine Responses of Koalas (Phascolarctos cinereus) Vaccinated with Recombinant Chlamydial Major Outer Membrane Protein (MOMP) with Two Different Adjuvants. PLoS ONE. vol. 11 (5).
- (2016) Humoral immune responses in koalas (Phascolarctos cinereus) either naturally infected with Chlamydia pecorum or following administration of a recombinant chlamydial major outer membrane protein vaccine. Vaccine. vol. 34 (6).
- (2016) Treatment of Chlamydia-associated ocular disease via a recombinant protein based vaccine in the koala (Phascolarctos cinereus). Biologicals (Print). vol. 44 (6).
- (2016) Serum antibody response to koala retrovirus (KoRV) antigens varies in free-ranging koalas (Phascolarctos cinereus) in Australia: implications for vaccine design. Journal of Wildlife Diseases. vol. 52 (2).
- (2016) Koala translocations and Chlamydia: Managing risk in the effort to conserve native species. Biological Conservation. vol. 197.
- (2016) A Prototype Recombinant-Protein Based Chlamydia pecorum Vaccine Results in Reduced Chlamydial Burden and Less Clinical Disease in Free-Ranging Koalas (Phascolarctos cinereus). PLoS ONE. vol. 11 (1).
- (2015) Genetic diversity in the plasticity zone and the presence of the chlamydial plasmid differentiates Chlamydia pecorum strains from pigs, sheep, cattle, and koalas. BMC Genomics. vol. 16 (1).
- (2015) Identification, characterisation and expression analysis of natural killer receptor genes in Chlamydia pecorum infected koalas (Phascolarctos cinereus). BMC Genomics. vol. 16 (1).
- (2015) Comparison of subcutaneous versus intranasal immunization of male koalas (Phascolarctos cinereus) for induction of mucosal and systemic immunity against Chlamydia pecorum. Vaccine. vol. 33 (7).
- (2014) Detoxification enzyme activites (CYP1A1 and GST) in the skin of humpback whales as a function of organochlorine burdens and migration status. Aquatic Toxicology.
- (2014) Vaccination of koalas (Phascolarctos cinereus) with a recombinant chlamydial major outer membrane protein adjuvanted with poly I:C, a host defense peptide and polyphosphazine, elicits strong and long lasting cellular and humoral immune responses. Vaccine. vol. 32 (44).
- (2014) Interleukin 17A is an immune marker for chlamydial disease severity and pathogenesis in the koala (Phascolarctos cinereus). Developmental and Comparative Immunology.